StelaraActive Ingredient(s): Ustekinumab
FDA Approved: * September 25, 2009
Pharm Company: * CENTOCOR ORTHO BIOTECH INC
Ustekinumab, sold under the brand name Stelara is a monoclonal antibody medication developed by Janssen Pharmaceuticals, for the treatment of Crohn's disease, ulcerative colitis, plaque psoriasis and psoriatic arthritis, targeting both IL-12 and IL-23. Ustekinumab is approved to treat Crohn's disease in the United States, Israel, Australia, and the European Union (EU), and ulcerative colitis in the US, and in the EU to patients who have not responded to m... [wikipedia]* May have multiple approval dates, manufacturers, or labelers.
Are you a patient with moderate to severe psoriasis that is currently taking or has taken biologic therapies in the past...3 REPLIES